Nicolson G L, Marchesi V T, Singer S J
J Cell Biol. 1971 Oct;51(1):265-72. doi: 10.1083/jcb.51.1.265.
Spectrin, a major protein constituent of mammalian red blood cell membrane preparations, has been localized on the inner surface of human red blood cell membranes by techniques that utilized specific ferritin-conjugated antibodies and fixation of membranes shortly after hemolysis so as to allow penetration of the ferritin-antibody labels. The labeling of spectrin was shown to be specific by the following criteria. (a) Nonhomologous ferritin-conjugated antibodies did not specifically bind to either membrane surface. (b) Blocking the membrane-bound spectrin with excess unconjugated antispectrin antibodies prevented ferritin-antibody labeling. (c) Removal of spectrin by treating the membrane preparation with a low ionic strength buffer containing ethylenediaminetetraacetate and beta-mercaptoethanol prevented labeling by specific ferritin-conjugated antibodies.
血影蛋白是哺乳动物红细胞膜制剂的主要蛋白质成分,通过利用特异性铁蛋白偶联抗体以及溶血后不久固定细胞膜以便铁蛋白 - 抗体标记物能够穿透的技术,已将其定位在人红细胞膜的内表面。血影蛋白的标记通过以下标准显示是特异性的。(a) 非同源铁蛋白偶联抗体不会特异性结合到任何一个膜表面。(b) 用过量未偶联的抗血影蛋白抗体封闭膜结合的血影蛋白可阻止铁蛋白 - 抗体标记。(c) 用含有乙二胺四乙酸和β - 巯基乙醇的低离子强度缓冲液处理膜制剂以去除血影蛋白,可阻止特异性铁蛋白偶联抗体的标记。